Increasing advancements in biopharmaceuticals are augmenting the market at a healthy CAGR of ~4.9% during the forecast period of 2021 to 2027 :
the global host cell contaminant testing market is expected to register a CAGR of ~4.9% from 2021to 2027 and hold a value of over ~USD 400 million in 2027.
Read More